Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow May 18, 2023
Kane Biotech Announces Distribution Agreement with ProgenaCare Global for its coactiv+™ Antimicrobial Wound Gel Apr 20, 2023
Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow Apr 13, 2023
Kane Biotech Announces Proposed Amendments to its Credit Facility and Changes to its Board of Directors Mar 1, 2023
Kane Biotech’s Coactiv+™ Technology Could Address a Pricey and Painful Problem: Lack of Healing in Chronic Wounds Due to Microbial Biofilm Formation Feb 6, 2023
